GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » ROE % Adjusted to Book Value

Pet Pharm Biotech Co (ROCO:7762) ROE % Adjusted to Book Value : 1.45% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co ROE % Adjusted to Book Value?

Pet Pharm Biotech Co's ROE % for the quarter that ended in Dec. 2024 was 4.16%. Pet Pharm Biotech Co's PB Ratio for the quarter that ended in Dec. 2024 was 2.87. Pet Pharm Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 1.45%.


Pet Pharm Biotech Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Pet Pharm Biotech Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co ROE % Adjusted to Book Value Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - 1.03

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value - - - - 1.45

Competitive Comparison of Pet Pharm Biotech Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pet Pharm Biotech Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pet Pharm Biotech Co's ROE % Adjusted to Book Value falls into.


;
;

Pet Pharm Biotech Co ROE % Adjusted to Book Value Calculation

Pet Pharm Biotech Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.91% / 2.83
=1.03%

Pet Pharm Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.16% / 2.87
=1.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pet Pharm Biotech Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pet Pharm Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines